Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonino Grassadonia

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Current Opinion in Supportive and Palliative Care|August 8, 2019
From cachexia to obesity: the role of host metabolism in cancer immunotherapyDavide Brocco, Pietro Di Marino, Antonino Grassadonia
Disease Markers|December 19, 2013
Circulating autoantibodies to LGALS3BP: a novel biomarker for cancerAntonino Grassadonia, Nicola Tinari, Clara Natoli, et al.
Frontiers in Endocrinology|December 23, 2021
Hormonal Regulation of the MHC Class I Gene in Thyroid Cells: Role of the Promoter "Tissue-Specific" RegionCesidio Giuliani, Sara Verrocchio, Fabio Verginelli, et al.
Cancers|November 9, 2013
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid MalignanciesAntonino Grassadonia, Pasquale Cioffi, Felice Simiele, et al.
The Journal of Investigative Dermatology|August 8, 2002
Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesionsAnna Maria Cesinaro, Clara Natoli, Antonino Grassadonia, et al.
Medical Hypotheses|November 27, 2012
Tumor-derived microvesicles: the metastasomesReza Ghasemi, Antonino Grassadonia, Nicola Tinari, et al.
Cancers|July 15, 2020
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular PerspectiveDavide Brocco, Rosalba Florio, Laura De Lellis, et al.
Cancer Biology & Therapy|November 11, 2015
Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?Vincenzo Graziano, Maria Teresa Scognamiglio, Marinella Zilli, et al.
Current Cancer Drug Targets|February 8, 2012
An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitorsNicola Tinari, Michele De Tursi, Antonino Grassadonia, et al.
International Medical Case Reports Journal|March 28, 2020
Alectinib Induced Regression of Renal and Hepatic Cysts Caused by CrizotinibPietro Di Marino, Gianluca Mannetta, Consiglia Carella, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Current Opinion in Supportive and Palliative Care|August 8, 2019
From cachexia to obesity: the role of host metabolism in cancer immunotherapyDavide Brocco, Pietro Di Marino, Antonino Grassadonia
Disease Markers|December 19, 2013
Circulating autoantibodies to LGALS3BP: a novel biomarker for cancerAntonino Grassadonia, Nicola Tinari, Clara Natoli, et al.
Frontiers in Endocrinology|December 23, 2021
Hormonal Regulation of the MHC Class I Gene in Thyroid Cells: Role of the Promoter "Tissue-Specific" RegionCesidio Giuliani, Sara Verrocchio, Fabio Verginelli, et al.
Cancers|November 9, 2013
Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid MalignanciesAntonino Grassadonia, Pasquale Cioffi, Felice Simiele, et al.
The Journal of Investigative Dermatology|August 8, 2002
Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesionsAnna Maria Cesinaro, Clara Natoli, Antonino Grassadonia, et al.
Medical Hypotheses|November 27, 2012
Tumor-derived microvesicles: the metastasomesReza Ghasemi, Antonino Grassadonia, Nicola Tinari, et al.
Cancers|July 15, 2020
The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular PerspectiveDavide Brocco, Rosalba Florio, Laura De Lellis, et al.
Cancer Biology & Therapy|November 11, 2015
Is the skin a sanctuary for breast cancer cells during treatment with anti-HER2 antibodies?Vincenzo Graziano, Maria Teresa Scognamiglio, Marinella Zilli, et al.
Current Cancer Drug Targets|February 8, 2012
An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitorsNicola Tinari, Michele De Tursi, Antonino Grassadonia, et al.
International Medical Case Reports Journal|March 28, 2020
Alectinib Induced Regression of Renal and Hepatic Cysts Caused by CrizotinibPietro Di Marino, Gianluca Mannetta, Consiglia Carella, et al.
Pageof 9